Current News

Contact | Print version | PDF version | Send article | RSS-Feed

Hana Biosciences annouces vice president appointments in clinical operations and corporate development

09 Jan 2007 - Hana Biosciences announced the promotion of Gavin S. Choy, Pharm.D. and Alex Tkachenko, Ph.D. In their new roles, Dr. Choy will be responsible for all clinical operations as Vice President, Clinical Operations, while Dr. Tkachenko gains added responsibility overseeing Hana's business development as Vice President, Corporate Development and Strategic Planning.
 
Dr. Choy has been a Senior Director of Clinical Operations at Hana Biosciences since September 2004. Prior to joining Hana, Dr. Choy was a Clinical Scientist at Gilead Sciences, Inc. Prior to joining Gilead, Dr. Choy was a clinical pharmacist practicing in the areas of oncology, hematology and bone marrow transplant at Stanford University Hospital, Stanford CA. and at the Department of Veteran Affairs in Sepulveda, CA. Prior to that, Dr. Choy was a Director, Geriatric Residency Program, at the Department of Veterans Affairs in Sepulveda. Concurrent with these positions, Dr. Choy also served as an Assistant Clinical Professor of Pharmacy at the University of California, San Francisco and the University of Southern California, until 2000. Dr. Choy completed Residency in Geriatric Pharmacy Practice and earned a Doctorate of Pharmacy from the University of Southern California, and a Master of Business Administration from the University of California, Irvine.
 
Since 2005, Dr. Tkachenko has been Hana's Senior Director, Business Development and Operations Planning responsible for product licensing and partnership management. Prior to joining Hana, Dr. Tkachenko was employed by Genentech, Inc., most recently as an Associate Director in its development organization. Earlier, as Product Manager for RituxanŽ, Dr. Tkachenko helped lead a cross-functional effort to prepare the brand for the impact of Medicare reimbursement reform. Dr. Tkachenko earned a Ph.D. in Molecular Biology from the University of Medicine and Dentistry of New Jersey and an MBA from Harvard Business School.